GlassScriptPhysician profile
Steven R Winham
NPI 1871971341
$9,889.25
in general payments reported to CMS, 2019-2025
11 companies · $370 in 2025
The $370 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,322 · 2020: $507 · 2022: $1,427 · 2023: $110 · 2024: $152 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $8,514.67 | 2019-2022 | |
| Stryker Corporation | $599.80 | 2020-2025 | Triathlon, Mako |
| Arcuro Medical INC | $225.62 | 2025 | Superball |
| Boston Scientific Corporation | $127.70 | 2022 | |
| Ferring Pharmaceuticals INC. | $112.10 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $95.63 | 2023-2025 | Iovera, Exparel, Zilretta |
| Exactech, INC. | $86.13 | 2020 | |
| Si-Bone, INC. | $52.10 | 2023 | |
| Heron Therapeutics, INC. | $44.65 | 2022-2024 | Zynrelef |
| Karl Storz Endoscopy-America | $17.97 | 2020 | |
| Pacira Therapeutics, INC. | $12.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Winham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.